Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 6/2018

01-07-2018 | Original Paper

Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?

Authors: Roland Linder, J. Zeidler, F. Verheyen, J.-M. Graf von der Schulenburg, A. Haverich, T. Schilling

Published in: The European Journal of Health Economics | Issue 6/2018

Login to get access

Abstract

The national guidelines for treatment of chronic coronary heart disease (CHD) recommend surgical coronary aortic bypass grafting (CABG) rather than percutaneous coronary intervention (PCI) for patients with a coronary three-vessel disease. The epidemiology of three-vessel CHD and data about the application of different revascularisation strategies raise suspicion of deviation from the guidelines in the treatment of those patients. Claims data containing records of almost 10 million patients of the largest German statutory health insurance fund (Techniker Krankenkasse) were utilised to measure adherence to the guidelines for treatment of groups of patients with one-, two-, and three-vessel CHD, respectively. The impact of age, sex, and comorbidity on each patient’s revascularisation procedure was investigated as well. There was no significant difference in the rate of PCI between the groups. In conclusion, the hypothesis that patients with a coronary three-vessel disease are not always treated according to the recommendations of the national guidelines could not be disproved by this study. Finally, the results of this study suggest that the best revascularisation strategy for each patient with two- and three-vessel disease should be decided upon by an interdisciplinary discussion between both cardiologists and cardiac surgeons.
Literature
1.
Benedetto, U., Gaudino, M., Ng, C., Biondi-Zoccai, G., D’Ascenzo, F., Frati, G., Girardi, L.N., Angelini, G.D., Taggart, D.P.: Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials. Int. J. Cardiol. 210, 19–24 (2016). doi:10.​1016/​j.​ijcard.​2016.​02.​090 CrossRefPubMed
2.
Mohr, F.W., Morice, M.C., Kappetein, A.P., Feldman, T.E., Stahle, E., Colombo, A., Mack, M.J., Holmes Jr., D.R., Morel, M.A., van Dyck, N., Houle, V.M., Dawkins, K.D., Serruys, P.W.: Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381(9867), 629–638 (2013)CrossRefPubMed
3.
Weintraub, W.S., Grau-Sepulveda, M.V., Weiss, J.M., O’Brien, S.M., Peterson, E.D., Kolm, P., Zhang, Z., Klein, L.W., Shaw, R.E., McKay, C., Ritzenthaler, L.L., Popma, J.J., Messenger, J.C., Shahian, D.M., Grover, F.L., Mayer, J.E., Shewan, C.M., Garratt, K.N., Moussa, I.D., Dangas, G.D., Edwards, F.H.: Comparative effectiveness of revascularization strategies. N. Engl. J. Med. 366(16), 1467–1476 (2012)CrossRefPubMedPubMedCentral
4.
Kappetein, A.P., Feldman, T.E., Mack, M.J., Morice, M.C., Holmes, D.R., Stahle, E., Dawkins, K.D., Mohr, F.W., Serruys, P.W., Colombo, A.: Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur. Heart J. 32(17), 2125–2134 (2011)CrossRefPubMed
5.
Serruys, P.W., Morice, M.C., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., Stahle, E., Feldman, T.E., van den Brand, M., Bass, E.J., Van, D.N., Leadley, K., Dawkins, K.D., Mohr, F.W.: Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 360(10), 961–972 (2009)CrossRefPubMed
6.
Authors/Task Force, m, Windecker, S., Kolh, P., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S.J., Juni, P., Kappetein, A.P., Kastrati, A., Knuuti, J., Landmesser, U., Laufer, G., Neumann, F.J., Richter, D.J., Schauerte, P., Sousa Uva, M., Stefanini, G.G., Taggart, D.P., Torracca, L., Valgimigli, M., Wijns, W., Witkowski, A.: 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35(37), 2541–2619 (2014). doi:10.​1093/​eurheartj/​ehu278 CrossRef
7.
Biancari, F., Myllyl, M., Lepojrvi, S., Kuttila, K., Porela, P., Laitio, T., Ylitalo, A., Jokinen, V., Luokkala, A., Airaksinen, K.E.: Preoperative warfarin treatment and outcome of coronary artery bypass graft surgery. Ann. Thorac. Surg. 89(4), 1139–1145 (2010)CrossRefPubMed
8.
Cohen, D.J., Lavelle, T.A., Van Hout, B., Li, H., Lei, Y., Robertus, K., Pinto, D., Magnuson, E.A., McGarry, T.F., Lucas, S.K., Horwitz, P.A., Henry, C.A., Serruys, P.W., Mohr, F.W., Kappetein, A.P.: Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter. Cardiovasc. Interv. 79(2), 198–209 (2012)CrossRefPubMed
9.
Serruys, P.W., Unger, F., Sousa, J.E., Jatene, A., Bonnier, H.J., Schonberger, J.P., Buller, N., Bonser, R., van den Brand, M.J., van Herwerden, L.A., Morel, M.A., van Hout, B.A.: Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N. Engl. J. Med. 344(15), 1117–1124 (2001)CrossRefPubMed
10.
Bundesärztekammer, Kassenärztliche, B., Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen, F.: Nationale VersorgungsLeitlinie Chronische KHK—Langfassung, vol. 2. Aerztliches Zentrum fuer Qualitaet in der Medizin, Berlin (2013)
11.
Beckmann, A., Funkat, A.K., Lewandowski, J., Frie, M., Schiller, W., Hekmat, K., Gummert, J.F., Mohr, F.W.: Cardiac surgery in Germany during 2012: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac. Cardiovasc. Surg. 62(1), 5–17 (2014)PubMed
12.
Bruckenberger, E.: Multidisciplinary health report on cardiology and cardiac surgery, vol. 25. Deutsche Herzstiftung, Hannover (2013)
13.
Kimura, T., Morimoto, T., Furukawa, Y., Nakagawa, Y., Kadota, K., Iwabuchi, M., Shizuta, S., Shiomi, H., Tada, T., Tazaki, J., Kato, Y., Hayano, M., Abe, M., Tamura, T., Shirotani, M., Miki, S., Matsuda, M., Takahashi, M., Ishii, K., Tanaka, M., Aoyama, T., Doi, O., Hattori, R., Tatami, R., Suwa, S., Takizawa, A., Takatsu, Y., Takahashi, M., Kato, H., Takeda, T., Lee, J.D., Nohara, R., Ogawa, H., Tei, C., Horie, M., Kambara, H., Fujiwara, H., Mitsudo, K., Nobuyoshi, M., Kita, T.: Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc. Interv. Ther. 26(3), 234–245 (2011)CrossRefPubMed
14.
Schilling, T., Haverich, A.: The contradictory contexts of interdisciplinarity. Chirurg 83(4), 332–338 (2012)CrossRefPubMed
15.
Morice, M.C., Serruys, P.W., Kappetein, A.P., Feldman, T.E., Stahle, E., Colombo, A., Mack, M.J., Holmes, D.R., Choi, J.W., Ruzyllo, W., Religa, G., Huang, J., Roy, K., Dawkins, K.D., Mohr, F.: Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the SYNTAX trial. Circulation 129(23), 2388–2394 (2014)CrossRefPubMed
16.
Statistisches, B.: Bevoelkerung und Erwerbstaetigkeit. Bev”lkerungsfortschreibung. Statistisches Bundesamt, Wiesbaden (2013)
17.
Elixhauser, A., Steiner, C., Harris, D.R., Coffey, R.M.: Comorbidity measures for use with administrative data. Med. Care 36(1), 8–27 (1998)CrossRefPubMed
18.
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.C., Saunders, L.D., Beck, C.A., Feasby, T.E., Ghali, W.A.: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care 43(11), 1130–1139 (2005)CrossRefPubMed
19.
van Walraven, C., Austin, P.C., Jennings, A., Quan, H., Forster, A.J.: A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med. Care 47(6), 626–633 (2009)CrossRefPubMed
20.
Kappetein, A.P., Head, S.J., Morice, M.C., Banning, A.P., Serruys, P.W., Mohr, F.W., Dawkins, K.D., Mack, M.J.: Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur. J. Cardiothorac. Surg. 43(5), 1006–1013 (2013)CrossRefPubMed
21.
Serruys, P.W., Ong, A.T., van Herwerden, L.A., Sousa, J.E., Jatene, A., Bonnier, J.J., Schonberger, J.P., Buller, N., Bonser, R., Disco, C., Backx, B., Hugenholtz, P.G., Firth, B.G., Unger, F.: Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J. Am. Coll. Cardiol. 46(4), 575–581 (2005)CrossRefPubMed
22.
Tazaki, J., Shiomi, H., Morimoto, T., Imai, M., Yamaji, K., Sakata, R., Okabayashi, H., Hanyu, M., Shimamoto, M., Nishiwaki, N., Komiya, T., Kimura, T.: Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2. EuroIntervention 9(4), 437–445 (2013)CrossRefPubMed
23.
Thiem, A., Attmann, T., Cremer, J.: Moderne Koronarchirurgie in Zusammenhang mit der SYNTAX-Studie und aktuellen Leitlinien. Herz 36(8), 669–676 (2011)CrossRefPubMed
24.
Maier, W., Camici, P., Windecker, S., Pfiffner, D., Wijns, W., Meier, B.: The European registry of cardiac catheter interventions 1997. Eur. Heart J. 23(24), 1903–1907 (2002)CrossRefPubMed
25.
van Buuren, F., Horstkotte, D.: 24th report about the statistics of the heart catheterization laboratory in the German Federal Republic. Results of the joint inquiry of the Commission for Clinical Cardiology and of the Working Groups for Interventional Cardiology and Angiology of the German Society for Cardiology and Circulatory Research in the year 2007. Kardiologie 3, 512–518 (2009)CrossRef
26.
Hoffmann, F., Icks, A.: Unterschiede in der Versichertenstruktur von Krankenkassen und deren Auswirkungen für die Versorgungsforschung: Ergebnisse des Bertelsmann-Gesundheitsmonitors. Gesundheitswesen 74(5), 291–297 (2012)CrossRefPubMed
27.
Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Magid, D., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., Moy, C.S., Mussolino, M.E., Nichol, G., Paynter, N.P., Schreiner, P.J., Sorlie, P.D., Stein, J., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B.: Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127(1), e6–e245 (2013)CrossRefPubMed
28.
Lange, C.: Daten und Fakten: Ergebnisse der Studie “Gesundheit in Deutschland aktuell 2010”. Berlin (2012)
29.
Farkouh, M.E., Domanski, M., Sleeper, L.A., Siami, F.S., Dangas, G., Mack, M., Yang, M., Cohen, D.J., Rosenberg, Y., Solomon, S.D., Desai, A.S., Gersh, B.J., Magnuson, E.A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J.E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C.R., Muratov, V., Bansilal, S., King 3rd, S., Bertrand, M., Fuster, V., Investigators, F.T.: Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 367(25), 2375–2384 (2012). doi:10.​1056/​NEJMoa1211585 CrossRefPubMed
30.
31.
Nam, C.W., Mangiacapra, F., Entjes, R., Chung, I.S., Sels, J.W., Tonino, P.A., de Bruyne, B., Pijls, N.H., Fearon, W.F.: Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J. Am. Coll. Cardiol. 58(12), 1211–1218 (2011)CrossRefPubMed
32.
Pijls, N.H., van Schaardenburgh, P., Manoharan, G., Boersma, E., Bech, J.W., Van’t Veer, M., Bar, F., Hoorntje, J., Koolen, J., Wijns, W., de Bruyne, B.: Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J. Am. Coll. Cardiol. 49(21), 2105–2111 (2007)CrossRefPubMed
33.
Nashef, S.A., Roques, F., Michel, P., Gauducheau, E., Lemeshow, S., Salamon, R.: European system for cardiac operative risk evaluation (EuroSCORE) 1. Eur. J. Cardiothorac. Surg. 16(1), 9–13 (1999)CrossRefPubMed
34.
Nilsson, J., Algotsson, L., Hoglund, P., Luhrs, C., Brandt, J.: Comparison of 19 pre-operative risk stratification models in open-heart surgery 1. Eur. Heart J. 27(7), 867–874 (2006)CrossRefPubMed
Metadata
Title
Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?
Authors
Roland Linder
J. Zeidler
F. Verheyen
J.-M. Graf von der Schulenburg
A. Haverich
T. Schilling
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 6/2018
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-017-0924-4

Other articles of this Issue 6/2018

The European Journal of Health Economics 6/2018 Go to the issue

Original Paper

Measuring the end-of-life premium in cancer using individual ex ante willingness to pay

Original Paper

Estimating a constant WTP for a QALY—a mission impossible?

Original Paper

Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death?

Original Paper

Uncontrolled diabetes and health care utilisation: panel data evidence from Spain

Original Paper

Does the use of the proportional shortfall help align the prioritisation of health services with public preferences?

Original Paper

Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy